Enveric Biosciences, Inc.
Enveric Biosciences, Inc.（ENVB）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · ENVB · 截至 2026年6月9日
活动摘要
买入笔数
1
P-Purchase only
卖出笔数
0
近12个月
买卖比
∞
Buy/Sell (by trades)
整体情绪
Enveric Biosciences, Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
ENVB 季度内部人买卖趋势
ENVB 内幕交易卖出 · ENVB 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · ENVB CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
ENVB 高管卖出股份 · ENVB 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Dec 23, 2025 | DeWitt Sheila Director | Award | 7,633 | — | Form 4 |
| Dec 23, 2025 | Kegler George A. Director | Award | 7,633 | — | Form 4 |
| Dec 23, 2025 | PASQUALONE FRANK Director | Award | 7,633 | — | Form 4 |
| Dec 23, 2025 | Schabacker Marcus Director | Award | 7,633 | — | Form 4 |
| Dec 23, 2025 | Tucker Joseph Edward CEO · Director | Award | 60,296 | — | Form 4 |
| Dec 23, 2025 | WEBB MICHAEL D Director | Award | 7,633 | — | Form 4 |
| Dec 23, 2025 | Coveney Kevin Michael CFO | Award | 40,198 | — | Form 4 |
| May 8, 2025 | Coveney Kevin Michael CHIEF FINANCIAL OFFICER | Award | 74,150 | — | Form 4 |
| May 8, 2025 | Facchini Peter J. CHIEF INNOVATION OFFICER | Award | 24,717 | — | Form 4 |
| May 8, 2025 | Tucker Joseph Edward CHIEF EXECUTIVE OFFICER · Director | Award | 98,866 | — | Form 4 |
| Oct 9, 2024 | DeWitt Sheila Director | Award | 27,845 | — | Form 4 |
| Oct 9, 2024 | Kegler George A. Director | Award | 47,733 | — | Form 4 |
| Oct 9, 2024 | Schabacker Marcus Director | Award | 47,733 | — | Form 4 |
| Oct 9, 2024 | WEBB MICHAEL D Director | Award | 47,733 | — | Form 4 |
| Oct 9, 2024 | PASQUALONE FRANK Director | Award | 47,733 | — | Form 4 |
| Oct 9, 2024 | Tucker Joseph Edward CHIEF EXECUTIVE OFFICER · Director | Award | 161,633 | — | Form 4 |
| Oct 9, 2024 | Facchini Peter J. CHIEF INNOVATION OFFICER | Award | 40,000 | — | Form 4 |
| Oct 9, 2024 | Coveney Kevin Michael CHIEF FINANCIAL OFFICER | Award | 100,000 | — | Form 4 |
| Feb 22, 2024 | Tucker Joseph Edward CHIEF EXECUTIVE OFFICER · Director | Award | 100,000 | — | Form 4 |
| Feb 22, 2024 | Facchini Peter J. CHIEF INNOVATION OFFICER | Award | 50,000 | — | Form 4 |
| Feb 22, 2024 | Coveney Kevin Michael CHIEF FINANCIAL OFFICER | Award | 60,000 | — | Form 4 |
| Sep 15, 2023 | PASQUALONE FRANK Director | Purchase | 1,000 | $2K | Form 4 |
| Mar 13, 2023 | Coveney Kevin Michael CFO | Award | 26,500 | — | Form 4 |
| Jan 25, 2023 | Facchini Peter J. Chief Innovation Officer | Award | 17,000 | — | Form 4 |
| Jan 25, 2023 | Hagel Jillian Marie Vice President of Innovation | Award | 12,000 | — | Form 4 |
Tucker Joseph Edward
CHIEF EXECUTIVE OFFICER · Director
日期
May 8
股数
98,866
均价
—
总金额
—
Tucker Joseph Edward
CHIEF EXECUTIVE OFFICER · Director
日期
Oct 9
股数
161,633
均价
—
总金额
—
Tucker Joseph Edward
CHIEF EXECUTIVE OFFICER · Director
日期
Feb 22
股数
100,000
均价
—
总金额
—
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 ENVB 内幕交易
ENVB 内幕交易
Enveric Biosciences, Inc.（ENVB）内幕交易数据来源于公司内部人（包括DeWitt Sheila (Director), Kegler George A. (Director), PASQUALONE FRANK (Director)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。ENVB内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Enveric Biosciences, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
ENVB 内幕交易 · 5个问题Enveric Biosciences, Inc.（ENVB）的内部人包括高管和董事，如DeWitt Sheila (Director), Kegler George A. (Director), PASQUALONE FRANK (Director)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026